Tao-Hua Lan

545 total citations
24 papers, 445 citations indexed

About

Tao-Hua Lan is a scholar working on Molecular Biology, Complementary and alternative medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tao-Hua Lan has authored 24 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Complementary and alternative medicine and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tao-Hua Lan's work include Traditional Chinese Medicine Analysis (9 papers), Ginseng Biological Effects and Applications (4 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Tao-Hua Lan is often cited by papers focused on Traditional Chinese Medicine Analysis (9 papers), Ginseng Biological Effects and Applications (4 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Tao-Hua Lan collaborates with scholars based in China, Thailand and Vietnam. Tao-Hua Lan's co-authors include Hongmei Tan, Xiongqing Huang, Huanlin Wu, Huiliang Qiu, Yiling Wu, Wei-Kang Wu, Wei Liu, Xiaoling Chen, Wenjun Pan and Zhi Wang and has published in prestigious journals such as Scientific Reports, Biochemical Pharmacology and European Journal of Pharmacology.

In The Last Decade

Tao-Hua Lan

22 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao-Hua Lan China 11 210 109 73 55 55 24 445
Pei Zhao China 16 315 1.5× 145 1.3× 92 1.3× 64 1.2× 62 1.1× 38 594
Mingtai Chen China 10 196 0.9× 66 0.6× 62 0.8× 44 0.8× 45 0.8× 44 426
Er‐shun Liang China 15 254 1.2× 124 1.1× 63 0.9× 32 0.6× 77 1.4× 21 540
Xiaoli Shan China 10 206 1.0× 97 0.9× 49 0.7× 33 0.6× 32 0.6× 22 377
Defeng Pan China 12 249 1.2× 124 1.1× 85 1.2× 28 0.5× 72 1.3× 40 558
Aijun Liu China 11 128 0.6× 109 1.0× 97 1.3× 39 0.7× 30 0.5× 23 379
Ya‐Ge Jin China 15 306 1.5× 176 1.6× 32 0.4× 32 0.6× 57 1.0× 18 613
Zhaojun Xiong China 15 272 1.3× 136 1.2× 32 0.4× 32 0.6× 66 1.2× 29 623
Yuanyuan Tie China 7 230 1.1× 88 0.8× 37 0.5× 36 0.7× 40 0.7× 7 415

Countries citing papers authored by Tao-Hua Lan

Since Specialization
Citations

This map shows the geographic impact of Tao-Hua Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao-Hua Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao-Hua Lan more than expected).

Fields of papers citing papers by Tao-Hua Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao-Hua Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao-Hua Lan. The network helps show where Tao-Hua Lan may publish in the future.

Co-authorship network of co-authors of Tao-Hua Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Tao-Hua Lan. A scholar is included among the top collaborators of Tao-Hua Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao-Hua Lan. Tao-Hua Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Tao-Hua, et al.. (2025). Impact of macro factors on country-level entrepreneurship: evidence from an empirical panel data study. Humanities and Social Sciences Communications. 12(1).
2.
Zhang, Fenglin, Wenhua Shi, Jianfei Wen, et al.. (2025). Elevated body roundness index increases the risk of cardiovascular disease in Chinese patients with circadian syndrome. Frontiers in Endocrinology. 16. 1532344–1532344.
3.
Lin, Hong, Wenjing Xu, Tao-Hua Lan, et al.. (2024). The association between frailty and the risk of mortality in critically ill congestive heart failure patients: findings from the MIMIC-IV database. Frontiers in Endocrinology. 15. 1424257–1424257. 1 indexed citations
4.
Lan, Tao-Hua, Yunshan Wu, Lin Jiao, et al.. (2024). Integrating Network Pharmacology and Experimental Validation to Investigate the Mechanism of Qushi Huatan Decoction Against Coronary Heart Disease. Drug Design Development and Therapy. Volume 18. 4033–4049. 2 indexed citations
5.
Ou, Xiaomin, et al.. (2024). Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE-/- Mice. Chinese Journal of Integrative Medicine. 30(10). 896–905. 2 indexed citations
6.
Wei, Xiao‐Hong, et al.. (2023). XinLi formula, a traditional Chinese decoction, alleviates chronic heart failure via regulating the interaction of AGTR1 and AQP1. Phytomedicine. 113. 154722–154722. 7 indexed citations
7.
Lan, Tao-Hua, Wei Jiang, Tong Liu, et al.. (2022). Metabolism disorder promotes isoproterenol-induced myocardial injury in mice with high temperature and high humidity and high-fat diet. BMC Cardiovascular Disorders. 22(1). 133–133. 16 indexed citations
8.
Lan, Tao-Hua, et al.. (2022). LOX-1 Regulation in Anti-atherosclerosis of Active Compounds of Herbal Medicine: Current Knowledge and the New Insight. Chinese Journal of Integrative Medicine. 29(2). 179–185. 1 indexed citations
9.
Lan, Tao-Hua, et al.. (2022). Nontargeted Metabolomic Profiling of Huo-Tan-Chu-Shi Decoction in the Treatment of Coronary Heart Disease with Phlegm-damp Syndrome. Cardiology Research and Practice. 2022. 1–11. 3 indexed citations
10.
Lan, Tao-Hua, et al.. (2021). Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis. Chinese Journal of Integrative Medicine. 27(11). 867–873. 4 indexed citations
13.
Lan, Tao-Hua, et al.. (2018). Systems Pharmacology Dissection of Traditional Chinese Medicine Wen‐Dan Decoction for Treatment of Cardiovascular Diseases. Evidence-based Complementary and Alternative Medicine. 2018(1). 5170854–5170854. 9 indexed citations
15.
Lan, Tao-Hua, et al.. (2017). Ginsenoside Rb1 prevents homocysteine-induced EPC dysfunction via VEGF/p38MAPK and SDF-1/CXCR4 activation. Scientific Reports. 7(1). 13061–13061. 21 indexed citations
16.
17.
Yu, Lin, Yunfei Wang, Jingwei Chen, et al.. (2014). Efficacy and Safety of Huxin Formula in Patients after CABG: A Multicenter, Double-Blind, Randomized Clinical Trial. Complementary Medicine Research. 21(6). 351–359. 2 indexed citations
18.
Lan, Tao-Hua, Xiongqing Huang, & Hongmei Tan. (2013). Vascular fibrosis in atherosclerosis. Cardiovascular Pathology. 22(5). 401–407. 134 indexed citations
19.
Lan, Tao-Hua, et al.. (2011). Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition. Biochemical Pharmacology. 82(2). 148–155. 55 indexed citations
20.
Lan, Tao-Hua, et al.. (2010). The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine. Journal of Vascular Surgery. 53(1). 156–164. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026